A
Anthony R. Sambol
Researcher at University of Nebraska Medical Center
Publications - 27
Citations - 3035
Anthony R. Sambol is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Public health & Virus. The author has an hindex of 13, co-authored 27 publications receiving 2867 citations.
Papers
More filters
Journal ArticleDOI
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca Garten,C. Todd Davis,Colin A. Russell,Colin A. Russell,Bo Shu,Stephen Lindstrom,Amanda Balish,Wendy Sessions,Xiyan Xu,Eugene Skepner,Varough M. Deyde,Margaret Okomo-Adhiambo,Larisa V. Gubareva,John R. Barnes,Catherine B. Smith,Shannon L. Emery,Michael J. Hillman,Pierre Rivailler,James A. Smagala,Miranda de Graaf,Miranda de Graaf,David F. Burke,Ron A. M. Fouchier,Claudia Pappas,Celia Alpuche-Aranda,Hugo López-Gatell,Hiram Olivera,Irma Lopez,Christopher A. Myers,Dennis J. Faix,Patrick J. Blair,Cindy Yu,Kimberly M. Keene,P. David Dotson,David Boxrud,Anthony R. Sambol,Syed H. Abid,Kirsten St. George,Tammy L. Bannerman,Amanda L. Moore,David J. Stringer,Patricia Blevins,Gail J. Demmler-Harrison,Michele Ginsberg,Paula Kriner,Steve Waterman,Sandra Smole,Hugo Guevara,Edward A. Belongia,Patricia A. Clark,Sara T. Beatrice,Ruben O. Donis,Jacqueline M. Katz,Lyn Finelli,Carolyn B. Bridges,Michael W. Shaw,Daniel B. Jernigan,Timothy M. Uyeki,Derek J. Smith,Derek J. Smith,Derek J. Smith,Alexander Klimov,Nancy J. Cox +62 more
TL;DR: The lack of similarity between the 2009 A(H1N1) virus and its nearest relatives indicates that its gene segments have been circulating undetected for an extended period as mentioned in this paper.
Journal ArticleDOI
Evaluation of Multiple (3-Cycle) Decontamination Processing for Filtering Facepiece Respirators
Michael S. Bergman,Dennis J. Viscusi,Brian K. Heimbuch,Joseph D. Wander,Anthony R. Sambol,Ronald E. Shaffer +5 more
TL;DR: Three-cycle 3X processing of eight different methods of decontamination of N95 filtering facepiece respirators finds that a single application of some methods did not adversely affect laboratory performance, but physical damage varied by treatment method.
Journal ArticleDOI
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement.
Philip W. Smith,Arthur O. Anderson,George W. Christopher,Theodore J. Cieslak,G J Devreede,Glen A Fosdick,Carl B Greiner,John M Hauser,Steven H. Hinrichs,Kermit D. Huebner,Peter C. Iwen,Dawn Jourdan,Mark G. Kortepeter,V Paul Landon,Patricia A. Lenaghan,Robert E Leopold,LeRoy A. Marklund,James W. Martin,Sharon Medcalf,Robert J Mussack,Randall H Neal,Bruce S. Ribner,Jonathan Y Richmond,Chuck Rogge,Leo A Daly,Gary A. Roselle,Mark E. Rupp,Anthony R. Sambol,Joann E Schaefer,John Sibley,Andrew J. Streifel,Susanna G Von Essen,Kelly L. Warfield +32 more
TL;DR: The consensus recommendations are presented to standardize the planning, design, construction, and operation of BPCUs as one element of the U.S. preparedness effort.
Journal ArticleDOI
Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity
Kathleen A. Ross,Hyelee Loyd,Wuwei Wu,Lucas Huntimer,Shaheen Ahmed,Anthony R. Sambol,Scott Broderick,Zachary Flickinger,Krishna Rajan,Tatiana K. Bronich,Surya K. Mallapragada,Michael J. Wannemuehler,Susan Carpenter,Balaji Narasimhan +13 more
TL;DR: The studies performed indicated that the recombinant H53 antigen was a robust immunogen and the H53-based polyanhydride nanovaccine induced protective immunity against a low-pathogenic H5N1 viral challenge.
Journal ArticleDOI
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain Ebola Virus
Peter C. Iwen,Philip W. Smith,Angela L. Hewlett,Christopher J. Kratochvil,Steven J. Lisco,James N. Sullivan,Shawn G. Gibbs,John J. Lowe,Paul D. Fey,Vicki L. Herrera,Anthony R. Sambol,James L. Wisecarver,Steven H. Hinrichs +12 more
TL;DR: Hospitals in the United States have been asked to be prepared to test specimens from persons under investigation (PUIs) for EVD or patients known to have EVD.